A groundbreaking male birth control pill is advancing through clinical trials, marking a major step toward expanding ...

YCT-529, a hormone-free male birth control pill, has shown high effectiveness in animals and is now in human trials, marking ...

The University of Minnesota College of Pharmacy released research Wednesday that lays the groundwork for the first hormone-free male birth control pill to enter clinical trials. Currently, people with ...

A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...

Arcturus Therapeutics, based in San Diego, has proprietary enabling technologies: (i) LUNAR lipid-mediated delivery, (ii) self-transcribing and replicating mRNA (STARR) technology, and (iii ...

To advance the profession of pharmacy, foster an environment that values employee contributions, and support development through balance and accountability. To have fun, recognize our accomplishments, ...

Located on Fred Hutchinson Cancer Center's South Lake Union campus in Seattle, the COVID-19 Clinical Research Center opened in October 2020 as a new resource for clinical research advancement and ...

SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell ...